INmune Bio Opens Phase II in High Dose Cohort of INKmune™ Trial in Prostate Cancer
Medical review of Phase 1 cohorts demonstrated no safety issuesData to be presented at the 10th Annual Innate Killer Summit, March 3-5BOCA RATON, ...
INmune Bio, Inc.: INmune Bio Opens Phase II in High Dose Cohort of INKmune Trial in Prostate Cancer
Medical review of Phase 1 cohorts demonstrated no safety issuesData to be presented at the 10th Annual Innate Killer Summit, March 3-5 BOCA RATON, Fla, Feb. 12, 2025 (GLOBE NEWSWIRE) -- INmune Bio ...
Looking between cells: Light microscopy probe provides unprecedented view of extracellular matrix
Before arriving at Janelia three years ago, Postdoctoral Scientist Antonio Fiore was designing and building optical ...
Short-course radiation matches standard therapy for endometrial cancer
In a randomized clinical trial, researchers from Huntsman Cancer Institute at the University of Utah (the U) have found that ...
Science Daily23h
Breast cancers broadly defined by their genome architecture
Breast cancers at all stages are defined by the structure of their genomes, researchers find. Targeting these processes early is likely to offer unexpected therapeutic avenues.